4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001567619-22-013993
President and CEO sold 27,498 shares at $22.50 ($618,705)
- President and CEO acquired 27,498 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Coulie Bernard · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-07-11 | Exercise or conversion : show line 1 in the form | +15,000 | $2.08 | $31,200 | 74,273 | D |
| 2022-07-11 | Sale : show line 2 in the form | −15,000 | $22.50 | $337,500 | 59,273 | D |
| 2022-07-12 | Exercise or conversion : show line 3 in the form | +12,498 | $2.08 | $25,996 | 71,771 | D |
| 2022-07-12 | Sale : show line 4 in the form | −12,498 | $22.50 | $281,205 | 59,273 | D |
| Open-market sales · 27,498 sh · avg $22.50 · $618,705 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-07-11 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −15,000 | 322,380 | D |
| 2022-07-12 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −12,498 | 309,882 | D |
Loading xslF345X03/doc1.xml…